In this interview, Lawrence Goodwin (KCAS, KS, USA) explains his passion for tandem technology, the portfolio of services that KCAS offers and the advantages and disadvantages of their key technologies chromatography and mass spectrometry.
Take our short survey on large molecule quantification by LC–MS.
View time: 2:29 mins
In this interview, Anne Kleinnijenhuis (Triskelion; Zeist, The Netherlands) describes his current research focus, key challenges he faces when utilizing LC–MS and what he believes the future holds for the technology.
At PRA Health Sciences, we recognize that the world of clinical development is complex and dynamic, and we’ve designed our bioanalytical laboratories to meet those challenges. Proactive and always looking to the future, we provide the technology, innovative approaches, and high scientific standards required to deliver industry-leading laboratory servic
Sanofi (Paris, France) have acquired Ablynx (Ghent, Belgium) for €3.9 billion, including Ablynx’s Nanobody® technology platform and late-stage caplacizumab treatment.
In part 2 of this 3-part panel discussion our panelists discuss the exciting topic of regulations as they consider the ICH M10 guidance and where they think the field might be going in the future.
In late 2017 Bioanalysis and Bioanalysis Zone organized a panel discussion comprising of experts from leading CROs and pharmaceutical companies to converse about the latest topics in bioanalysis.
In this series of three panel discussions, key opinion leaders from both industries returned to partake in an open dialogue talking through the latest challenges the industry is facing and what changes they would like to see happen in the coming future.
In part 1 of this 3-part panel discussion filmed in Barcelona our panel of experts discuss the issue of outsourcing and what priorities need considering when making a purchasing decision.
In the final part of this 3-part panel discussion, our experts talk through the recent changes in the type of molecules and technologies the field are working with and what new technologies need to emerge to overcome current problems.
Take a look inside Bio-Rad’s custom recombinant antibody facility. Learn from our antibody experts how…